Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeability. - Blauvelt A; Bagel J; Pinter A; Thaçi D; Zhou M; Cao J; Mytych DT; Chow V; Franklin J (The British journal of dermatology, 2026)